First Results of the Swiss National Surgical Site Infection Surveillance Program: Who Seeks Shall Find. by Troillet, Nicolas et al.
Published in final form edited form as: Infect Control Hosp Epidemiol. 2017 Jun;38(6):697-704. doi: 10.1017/ice.2017.55 
 
First Results of the Swiss National Surgical Site Infection Surveillance 1 
Program: Who Seeks Shall Find 2 
Nicolas Troillet, MD, MSc;1,2,3 Emin Aghayev, MD;4 Marie-Christine Eisenring, CNS, ICP;1,2 Andreas F. 3 
Widmer, MD, MSc;1,5 Swissnoso 4 
 5 
1Swissnoso-National Center for Infection Control, Bern, Switzerland 6 
2Service of Infectious Diseases, Central Institute, Valais Hospital, Sion, Switzerland 7 
3Services of Preventive Medicine and Infectious Diseases, Centre Hospitalier Universitaire Vaudois and 8 
University of Lausanne, Switzerland; 9 
4Swiss RDL-Medical Registries and Data Linkage, Institute for Social and Preventive Medicine, 10 
University of Bern, Switzerland 11 
5Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Basel, Switzerland 12 
 13 
Address correspondence:  Nicolas Troillet, Central Institute, Valais Hospital, Ave. Grand-Champsec 86, 14 
Sion, CH 1950, Switzerland (nicolas.troillet@hopitalvs.ch). 15 
 16 
Financial support: No financial support was provided relevant to this article. 17 
 18 
Potential conflicts of interest: All authors report no conflicts of interest relevant to this article. 19 
  20 
s
o
u
r
c
e
:
 
h
t
t
p
s
:
/
/
d
o
i
.
o
r
g
/
1
0
.
7
8
9
2
/
b
o
r
i
s
.
1
0
9
2
0
7
 
|
 
d
o
w
n
l
o
a
d
e
d
:
 
2
7
.
1
2
.
2
0
2
0
Published in final form edited form as: Infect Control Hosp Epidemiol. 2017 Jun;38(6):697-704. doi: 10.1017/ice.2017.55 
 
4 Tables and 1 Figure 21 
Table 1: CDC/NHSN Criteria Used for the Diagnosis of Superficial Incisional SSI in Colon Surgery 22 
Table 2: Number of Operations and Hospitals Included in the Surveillance, Timing of Antibiotic 23 
Prophylaxis, and Surgical Technique, by Type of Operation 24 
Table 3 A, B, C: Adjusted Risk and Protective Factors for SSI After herniorraphy and C-Section, Including 25 
the Effect of the Time From the Initiation of Surveillance to the Operation (Time to Operation) 26 
Table 4: Adjusted Risk and Protective Factors for SSI After herniorraphy and C-Section, Including the 27 
Effect of the Time From the Initiation of Surveillance to the Operation (Time to Operation) 28 
Figure 1: Crude rates of surgical site infections (SSI) after herniorrhaphy and C-section according to 29 
the time from the initiation of surveillance to the date of the operation, by surgical procedure. 30 
  31 
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ABSTRACT 32 
Objectives: To report on the results of the Swiss national surgical site infection (SSI) surveillance 33 
program, including temporal trends, and to describe methodological characteristics that may 34 
influence SSI rates. 35 
Design: Countrywide survey of SSI over a 4-year period. Analysis of prospectively collected data 36 
including patient and procedure characteristics as well as aggregated SSI rates stratified by risk 37 
categories, type of SSI, and time of diagnosis. Temporal trends were analyzed using stepwise 38 
multivariate logistic regression models with adjustment of the effect of the duration of participation 39 
in the surveillance program for confounding factors. 40 
Setting: The study included 164 Swiss public and private hospitals with surgical activities. 41 
Results: From October 2011 to September 2015, a total of 187,501 operations performed in this 42 
setting were included. Cumulative SSI rates varied from 0.9% for knee arthroplasty to 14.4% for colon 43 
surgery. Postdischarge follow-up was completed in >90% of patients at 1 month for surgeries without 44 
an implant and in >80% of patients at 12 months for surgeries with an implant. High rates of SSIs were 45 
detected postdischarge, from 20.7% in colon surgeries to 93.3% in knee arthroplasties. Overall, the 46 
impact of the duration of surveillance was significantly and independently associated with a decrease 47 
in SSI rates in herniorraphies and C-sections but not for the other procedures. Nevertheless, some 48 
hospitals observed significant decreases in their rates for various procedures. 49 
Conclusions: Intensive post-discharge surveillance may explain high SSI rates and cause artificial 50 
differences between programs. Surveillance per se, without structured and mandatory quality 51 
improvement efforts, may not produce the expected decrease in SSI rates.  52 
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INTRODUCTION 53 
Surgical site infection (SSI) is the most frequent nosocomial infection in surgical patients. Depending 54 
on the type of surgical procedure, SSIs develop in <1% to >20% of patients after operation, and SSIs 55 
account for 38% of all nosocomial infections in this population.1–4 SSIs prolong hospital stay and 56 
increase costs, morbidity, and mortality.5–8 Secondary to the landmark study by Haley et al,9 57 
surveillance is considered an essential tool for the prevention of SSI.5,9,10 Many national programs have 58 
been set up for this purpose during the past 40 years. 59 
In Switzerland, a first multicenter surveillance system for SSIs was developed in the mid-1990s and 60 
progressively included hospitals from the southwestern part of the country 61 
until 2010.4,11,12 In 2009, the Swiss National Association for the Development of Quality in Hospitals 62 
and Clinics (ANQ) asked Swissnoso, the National Center for Infection Control, to implement a 63 
countrywide surveillance system for SSIs. In 2011, SSI surveillance became mandatory for Swiss 64 
hospitals with departments of surgery, and the 2 programs merged. This article reports on the results 65 
of this national surveillance system and describes its method, which includes continued on-site quality 66 
check of data generated by individual hospitals and high rates of follow-up. 67 
 68 
METHODS 69 
Description of the Surveillance Program 70 
The Swissnoso SSI surveillance system was developed according to the principles of the US National 71 
Nosocomial Infections Surveillance (NNIS) system, currently known as the National Healthcare Safety 72 
Network (NHSN).13,14 It is described in a practical guide written in the 3 national languages (German, 73 
French, and Italian), which is available for participating hospitals on the Swissnoso website 74 
(www.swissnoso.ch). 75 
Infection control nurses (ICNs), supervised by infectious diseases specialists or other physicians 76 
without a hierarchical link within the departments of surgery, orthopedics, or gynecology are in charge 77 
of the surveillance in each participating hospital. Surgeons do not take part actively in the process of 78 
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documenting SSIs. All ICNs and supervising physicians must attend a 1-day special training course 79 
before surveillance begins. SSIs are diagnosed according to the Centers for Diseases Control and 80 
Prevention (CDC) definitions and are classified as superficial incisional, deep incisional, or organ-space 81 
infections.15 Patients are followed-up during their hospital stay by ICNs through systematic reviews of 82 
patient charts, including medical and nursing notes, antibiotic use, microbiology and other laboratory 83 
or radiology results, and reports regarding operations, consultations, and discharges. The 84 
postdischarge follow-up is performed by ICNs through standardized phone interviews with each 85 
patient 1 month after the operation. A second interview takes place 12 months after surgeries with 86 
implants such as arthroplasties and cardiac surgeries. The follow-up survey comprises 6 questions 87 
regarding unplanned medical visits, rehospitalization, antibiotic prescription, and clinical symptoms of 88 
infection. At least 5 telephone attempts must be documented before a patient can be considered lost 89 
to follow-up. Any suspected or unclear case triggers further contacts with the family or hospital 90 
physician to gather any available additional information. Any suspicion of SSI or unclear situation is 91 
presented to the supervising physician for decision according to the CDC criteria. As an example, Table 92 
1 shows the criteria used for superficial SSIs secondary to colon surgery. Approximately every other 93 
year, 1-day onsite audits by Swissnoso supervisors take place in each participating hospital to evaluate 94 
the quality of the surveillance. These audits include comprehensive reviews of 15 randomly selected 95 
operations that have been included in the surveillance. 96 
Hospitals are free to choose at least 3 among 15 surgical procedures. However, those doing colon 97 
surgery must include this procedure. All patients undergoing the included procedures during given 98 
surveillance periods must be registered and followed-up. The variables collected include 99 
characteristics of the patients (sex, age, American Society of Anesthesiologists [ASA] score, and delay 100 
from admission to operation) and characteristics of the operations: contamination class, duration of 101 
the operation, planned or unplanned (ie, emergency) procedure, type and timing of antibiotic 102 
prophylaxis, minimally invasive or laparoscopic operation, multiple procedures during the surveyed 103 
operation, reoperation for noninfectious complications. Data are entered online in a university-104 
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owned, webbased database (www.ispm.unibe.ch), and each hospital has direct individual access to its 105 
results. Various data validation rules automatically apply during data entry. Inventory reports are 106 
available for every hospital, signaling cases to be completed or cases with possible errors. A hotline, 107 
staffed by Swissnoso collaborators, is available 5 of 7 days per week. 108 
Detailed reports are edited yearly for every participating hospital, allowing crude and adjusted 109 
comparisons with others, using the NNIS/NHSN risk index.14 The implementation or reinforcement of 110 
preventive measures is left to each hospital’s discretion. Participants are invited to an annual meeting 111 
where the results are presented and discussed. Since 2014, starting with the 2011 data, the Swiss 112 
National Association for the Development of Quality in Hospitals and Clinics (ANQ) has openly 113 
published the surveillance results by hospital (http://www.anq.ch/messergebnisse/ergebnisse-114 
akutsomatik/), including their names, NNIS/NHSN adjusted SSI rates, and quality of surveillance as 115 
rated during onsite visits. 116 
 117 
Statistical Analyses 118 
Analyses were performed on data collected from October 2011 to September 2015. Characteristics of 119 
the patients and operations, 4-year cumulative SSI rates (3-year for surgeries with implants), 120 
proportions of postdischarge diagnoses, and proportions of superficial incisional, deep incisional, and 121 
organ-space infections were calculated by type of surgical procedure. 122 
Because not all participating hospitals began the surveillance simultaneously, temporal trends in SSI 123 
rates were calculated for each surgical procedure taking the duration of participation in the 124 
surveillance program into account rather than calendar years. This duration was determined for each 125 
hospital and was stratified in 1-year periods, as described in previous studies.4,16 126 
Forward stepwise logistic regression models were developed for each surgical procedure that had 127 
been included for >2 years in the surveillance program to identify independent risk or protective 128 
factors for SSI, including the duration of participation in the program. The following covariates were 129 
entered in the initial models: time from the initiation of the surveillance to the surveyed operation, 130 
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patient sex, age, ASA score, delay from admission to operation, contamination class, duration of the 131 
operation, emergency procedure, antibiotic prophylaxis <1 h before incision, laparoscope use for 132 
digestive surgery, multiple procedures during the operation, and reoperation within the follow-up 133 
period for non-infectious complications. In surgical procedures where the time from the initiation of 134 
the surveillance to the surveyed operation was not initially retained as a significant covariate in the 135 
final model, it was added to obtain notwithstanding the effect of this variable independently of 136 
changes in patient characteristics over time. In addition, individual hospitals with significantly 137 
increasing or decreasing SSI rates over these time periods were identified using the Cochrane-138 
Armitage test.17 139 
Analyses were performed using SAS version 9.4 software (SAS Institute, Cary, NC). All tests were 1-140 
tailed, and α was set at 0.05 throughout the study. 141 
 142 
RESULTS 143 
Overall, 187,501 operations in 164 hospitals had been included in the surveillance system and could 144 
be analyzed (Table 2). Patient and operation characteristics, including age, sex, NNIS/NHSN risk index, 145 
contamination of the surgical wound, ASA score, and duration of the operation appeared similar to 146 
those reported in other large populations (Online Supplemental Table 1). Hysterectomies and 147 
laminectomies were included only in 2015 in the surveillance, explaining the smaller numbers of 148 
operations. Prophylactic antibiotics were often administered >1 hour before incision or after incision, 149 
showing room for improvement. In C-sections, antibiotics were still given late in 42.6% of the patients, 150 
after umbilical cord clamping. 151 
The aggregated rates of SSIs are shown in Table 3 by operation, globally, and stratified by NNIS/NHSN 152 
risk index category, by surgical technique (laparoscopic vs open) for digestive surgery, and by type of 153 
infection. Also shown in Table 3, 90% of the operations in digestive surgery were followed-up for 1 154 
month and >80% of surgeries with orthopedic implants and cardiac surgeries with foreign-material 155 
implants were followed-up for 1 year. Many SSIs occurred after discharge; these rates varied from 156 
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20.7% in colon surgery to 93.3% in knee arthroplasty. Taking all operations into account, 3,292 of 6,953 157 
SSIs (47.4%) were detected after discharge: 1,599 (48.6%) were superficial incisional, 521 (15.8%) were 158 
deep incisional, and 1,172 (35.6%) were organ-space infections. Rehospitalization occurred in 455 of 159 
1,599 (29.4%) patients with postdischarge superficial incisional SSIs, in 412 of 521 (79.1%) patients 160 
with postdischarge deep incisional SSIs, and in 1,129 of 1,172 (96.3%) patients with postdischarge 161 
organ-space infections. Mean and median times to the diagnosis of SSI varied respectively from 9.8 to 162 
17.6 days and 9 to 16 days for surgeries without implant, and from 29.9 to 83.2 and 17 to 34 days for 163 
surgeries with implant (Online Supplemental Table 2). A significant decrease was observed in 164 
operation-specific SSI rates of 27 hospitals or surgical departments over the observed time period, 165 
whereas a significant increase was observed in 11 hospitals (Online Supplemental Table 2). 166 
The effect of the time from the start of surveillance to the operation on SSI rates, as estimated by 167 
logistic regression models, is shown in Table 4 for herniorraphy and C-section, the 2 operations for 168 
which it remained an independent protective factor after adjustment for other factors. This effect is 169 
shown for all the types of operations in Online Supplemental Table 3. The trends of SSI rates according 170 
to this time are shown in Figure 1 for herniorrhaphy and C-section, and SSI trends are shown in Online 171 
Supplemental Figure 1 for each operation that had been included in the surveillance for >2 years. 172 
 173 
DISCUSSION 174 
Some SSI rates reported by our surveillance system may appear high in comparison with those 175 
reported in France, England, Germany, and the European Union and in the United States by the CDC’s 176 
National Healthcare Safety Network (NHSN).18–22 These rates are quite similar to those reported in the 177 
Netherlands by the PREZIES system and those reported in the United States by the American College 178 
of Surgeons National Surgical Quality Improvement Program (ACS NSQIP).23,24 Indeed, the Swissnoso 179 
system shares several characteristics with these 2 programs that distinguish their approach from other 180 
SSI surveillance systems and might contribute to the finding of higher SSI rates. 181 
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First, the Swissnoso program puts particular efforts in postdischarge surveillance (PDS) and reaches 182 
complete follow-up in the majority of included operations (from a minimum 82.8% in cardiac surgeries 183 
to 97% in rectal surgeries). Indeed, PDS is an important component of SSI surveillance, particularly in 184 
the current setting where hospital stays tend to be shorter and surgical procedures are more 185 
frequently performed in an ambulatory setting.5,25–27 As in other systems that also perform active 186 
PDS,24,26 high rates of SSI were detected postdischarge in our program, varying from 20.7% in colon 187 
surgeries to >90% in arthroplasties. In addition, 51.4% of the SSIs detected through PDS were severe 188 
(deep incisional or organ-space infections) and some of them, if not rehospitalized in the same hospital 189 
where the first operation took place, would not have been recognized without active PDS. 190 
However, no consensus exists on a method for PDS, and methodsmay differ between systems. We 191 
chose an indirect active method based on standardized phone interviews with the patients by trained 192 
ICNs, completed by a secondary contact with his/her general practitioner (GP) in case of a suspected 193 
SSI or an unclear situation.Written or oral questionnaires administered to patients or surgeons have 194 
low sensitivity and specificity for detecting SSIs.28,29 Nonetheless, Whitby et al29 found that the 195 
patient’s recall of prescription of an antibiotic by their GP for SSI during the postoperative period 196 
correlated very well with diagnoses made by experienced ICNs, particularly when confirmed by the 197 
GP in those patients reporting an infection. Our PDS is based on both a questionnaire administered to 198 
the patients by an ICN and a subsequent contact with their GPs, and we believe that it is a reliable and 199 
necessary tool for getting the correct figures to feed back to hospitals and surgical teams. Other 200 
systems based on electronic algorithms and/or administrative data may be less resource consuming, 201 
but they still need development to be used with heterogeneous information systems.30 Automated 202 
telephony could also help decrease the workload of IC nurses.31 203 
Second, since public reporting of SSI rates by hospitals became mandatory in Switzerland, important 204 
efforts were made to periodically audit hospitals to minimize risks of underreporting due to various 205 
possible biases that have been reported elsewhere and recently motivated specific recommendations 206 
from the US Healthcare Infection Control Practices Advisory Committee.32 Indeed, studies in Scotland, 207 
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the Netherlands, Australia, and New York state found 0.6% to 4.3% of SSIs among cases initially not 208 
reported as such.33–36 Our audits revealed differences between hospitals, particularly in the access to 209 
the necessary clinical information for ICNs to detect cases. They found 1.4% of false negatives, and 210 
0.09% of false positives (Kuster et al., Structure, Process and Outcome Quality of Surgical Site Infection 211 
Surveillance in Switzerland. Submitted. April 2017). Thus, to create incentives to perform better, 212 
Swissnoso gives marks to hospitals for the quality of their surveillance that are openly published 213 
together with their infection rates. Moreover, the same SSI case definitions may allow variable 214 
interpretations between persons and countries and could also result in artificial differences in SSI 215 
rates.37 216 
The main goal of SSI surveillance is to decrease SSI rates by providing hospitals, surgical teams, and 217 
stakeholders with data that can be used for benchmarking, monitoring, and, if deemed necessary, 218 
implementation of better preventive measures. Reaching this goal depends on factors that are 219 
external to the surveillance system and linked to hospitals or surgical departments themselves. 220 
Indeed, some individual hospitals or departments participating in our surveillance system experienced 221 
decreasing SSI rates in some operations over a 4-year observation period and others did not. But a 222 
general, statistically significant and independent protective effect on SSI of the duration of 223 
participation in the Swissnoso system was seen only for herniorrhaphy and C-section, whereas no 224 
significant trends were found for other surgeries. Such observations have already been made in other 225 
surveillance programs where SSI rates tend to decrease over time for some operations but not for 226 
others or even do increase.4,16,38,39 Various requirements have been listed for a surveillance system to 227 
succeed.40 They may be implemented at different levels of adherence among hospitals, within the 228 
same hospital, or among particular surgical teams. Overall, our results showed that the timing of 229 
antibiotic prophylaxis should be improved in most surgeries. Secondary to the initiation of 230 
surveillance, Swissnoso launched a new program aiming at introducing standardized process 231 
measures in hospitals for monitoring and improving some preventive measure for SSI such as hair 232 
removal, skin disinfection, and the dosing and timing of antibiotics. 233 
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In conclusion, a high-quality nationwide SSI surveillance program was implemented in Switzerland in 234 
2011. Its first results show high SSI rates as compared with other programs, but these differences may 235 
be, at least in part, artificial and due to methodological differences, particularly with respect to an 236 
effective PDS system that detected up to 47% of all SSIs, but this system is resource consuming and 237 
could benefit from future developments in information technology. In addition, regular on-site audits 238 
guarantee the quality of the collected data. To date, the ultimate goal of SSI surveillance (a decrease 239 
in SSI rates) has only been reached in a subset of patients and hospitals, but temporal trends are 240 
difficult to predict over a relatively short period of time. A longer observation period and additional 241 
efforts by hospitals may thus be necessary to reach this goal through projects based on a culture of 242 
safety such as those developed in the United States by the Comprehensive Unit-based Safety Program 243 
(CUSP) of the Armstrong Institute for Patient Safety and Quality. 244 
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TABLES 352 
Table 1 353 
CDC/NHSN Criteria Used for the Diagnosis of Superficial Incisional SSI in Colon Surgery 354 
Note: CDC, Centers for Disease Control and Prevention; NHSN, National Health Safety Network; SSI, surgical site infection. 355 
aMore than one criteria can be used for the same infection. 356 
 357 
 358 
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Table 2  360 
Number of Operations and Hospitals Included in the Surveillance, Timing of Antibiotic Prophylaxis, and Surgical Technique, by Type of Operationa 361 
Note: CABG, coronary arterial bypass. 362 
aTotal percentage may not equal 100 due to missing values or rounding 363 
 364 
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Table 3 A, B, C 366 
Adjusted Risk and Protective Factors for SSI After herniorraphy and C-Section, Including the Effect of the Time From the Initiation of Surveillance to the 367 
Operation (Time to Operation) 368 
Note: SSI, surgical site infection; CI, confidence interval; NNIS, National Nosocomial Infection Surveillance; NHSN, National Healthcare 369 
Security Network. 370 
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Table 4 375 
Adjusted Risk and Protective Factors for SSI After herniorraphy and C-Section, Including the Effect of the Time From the Initiation of Surveillance to the 376 
Operation (Time to Operation) 377 
Note: OR, odds ratio; CI, confidence interval; ASA, American Society of Anesthesiologists 378 
 379 
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FIGURE 381 
Figure 1  382 
Crude rates of surgical site infections (SSI) after herniorrhaphy and C-section according to the time 383 
from the initiation of surveillance to the date of the operation, by surgical procedure. 384 
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